Woman and Man
- | Country :
- Belgium
- | organs : -
- | Specialty : -
Extract
An open-label, Phase II clinical study to evaluate the efficacy and safety of lanreotide autogel 90mg every 4 weeks in the treatment of symptomatic polycystic liver disease, including a dose escalation at month 6 to lanreotide autogel 120mg for non responders.
Inclusion criteria
- Polycystic Liver Disease